ACNR Magazine

Anavex Life Sciences has withdrawn its European marketing authorisation application for blarcamesine, a potential treatment for early Alzheimer’s disease, following a negative assessment from regulators. The European Medicines Agency’s Committee for Medicinal Products for Human Use had concluded in December 2025 that the drug’s benefits did not outweigh its risks.

A new generation of surgical robotics has been introduced at the Royal Victoria Infirmary, marking a significant step forward in the delivery of highly precise neurosurgical procedures. The system is expected to enhance the treatment of patients with complex neurological conditions, including movement disorders such as Parkinson’s disease and epilepsy.

Venue: Macdonald Burlington Hotel Burlington Arcade Birmingham B2 4JQ Website: www.neurologyacademy.org This meeting offers a practical update on the diagnosis and management of multiple sclerosis (MS) and related inflammatory disorders. Expert speakers will cover evolving MS diagnostic criteria, investigation of suspected demyelination, interpretation of white matter lesions, and when to consider antibody-mediated conditions such as NMOSD and MOGAD.

Venue: Heraklion, Crete, Greece Website: www.fens.org Event Notes: This interdisciplinary conference brings together leading researchers exploring the neural and behavioral foundations of communication across species. Featured speakers studying human language will present their work, along with experts who focus on a range of diverse animal models, and those leveraging AI, jointly exploring the mechanisms of vocal learning, perception, and production.

Event Notes: Overview The Annual MS MDT conference is an educational meeting designed for healthcare professionals involved in the treatment, management, and support of people living with multiple sclerosis (MS). This full-day programme brings together expert speakers from across neurology, urology, psychology, and specialist nursing to explore current challenges, emerging evidence, and practical approaches to MS care.

Venue: Tsukuba, Ibaraki, Japan (In-Person) Website: ibro.org Event Notes: We will have the 2026 IBRO-APRC-supported Associate School at the University of Tsukuba (UT) for 8 days, starting on September 26 and ending on October 3, 2026. After a guidance session and a welcome event on the first day, we will have a 5-day training course with lectures, luncheon seminars, and interactive sessions.

Event Notes: The UKABIF Summit 2026 will take place on Monday 9th November at The Lowry, Pier 8, Salford Quays, Manchester, M50 3AZ. Related

Venue: Congress venue: CCIB (Barcelona International Convention Centre) Plaça de Willy Brandt, 11-14, 08019 Barcelona, Spain Website: www.ecnp.eu Event Notes: The annual ECNP Congress is Europe’s largest meeting in applied and translational neuroscience. Held every autumn, the ECNP Congress brings together psychiatrists, neuroscientists, neurologists and psychologists from around the world to discuss the latest developments in the science and treatment of brain disorders.

Event Notes: The IBRO World Congress is organized by the International Brain Research Organization and takes place every four years around the world. The IBRO 2027 World Congress is being organized with the support of the Southern African Neuroscience Society, the Regional Host. Related

Venue: Cavonius Centre at Gonville & Caius College in Cambridge Website: uksemiochemistry.com Following on from the success of the previous Symposia on Smell and Taste Disorders in 2022-4, Professor Carl Philpott will be hosting the 4th UK Symposium on Smell & Taste Disorders at the Cavonius Centre at Gonville & Caius College in Cambridge on the 4-5th June. This will be conducted in conjunction with the UK Semiochemistry Network Meeting (3-4th June).